期刊文献+

钙调蛋白激酶Ⅱ抑制剂抗肥厚心肌室性心律失常发生机制的研究 被引量:3

The Roles of Calmodulin Kinase Ⅱ Inhibitor in Ventricular Arrhythmias in Rabbits with Cardiac Hypertrophy
下载PDF
导出
摘要 目的探讨钙调蛋白激酶Ⅱ特异性抑制剂KN-93抗肥厚心肌室性心律失常发生的机制。方法雌性新西兰大白兔随机分为4组:假手术组(sham组)、心肌肥厚组(LVH组)、心肌肥厚+KN-93组(KN-93组)、心肌肥厚+KN-92组(KN-92组),每组14只。LVH组、KN-93组及KN-92组通过缩窄腹主动脉制备兔心肌肥厚模型。8周后,制备兔左室楔形心肌块的灌注模型,同步记录心内、外膜动作电位及跨壁心电图,观察低钾(2mmol/L)、低镁(0.25mmol/L)蒂罗德液灌流及慢频率(2000~4000ms)刺激条件下各组早期后除极(EAD)和尖端扭转型室性心动过速(Tdp)的发生率。采用胶原酶消化法分离单个心肌细胞,应用膜片钳技术记录动作电位(AP),观察低钾、低镁蒂罗德液灌流及慢频率(0.25~0.5Hz)刺激条件下,各组EAD的发生率。结果在低钾、低镁蒂罗德液灌流及慢频率刺激条件下,兔左室楔形心肌块水平,sham组、LVH组、KN-92组(0.5μmol/L)及KN-93组(0.5μmol/L)EAD的发生率分别为0/10、10/10、9/10和5/10,Tdp的发生率分别为0/10、5/10、4/10和1/10。单个心肌细胞水平,Sham组、LVH组、KN-92组(0.5μmol/L)及KN-93组(0.5μmol/L)EAD的发生率分别为0/12、11/12、10/12和5/12。结论钙调蛋白激酶Ⅱ介导心肌肥厚兔室性心律失常的发生,其主要作用机制是通过增加EAD的发生率,从而触发室性心律失常的发生。 Objective To investigate the role of calmodulin kinase Ⅱ on ventricular arrhythmias in rabbits with cardiac hypertrophy by use KN-93, a kind of ealmodulin kinase Ⅱ inhibitor. Methods Fifty-six female New Zealand white rabbits were randomly divided into 4 groups:sham group, LVH group, KN-92 group and KN-93 group. In LVH group, KN-92 group and KN-93 group, the abdominal aorta was partially constricted. Eight weeks later:①The arterially perfused left ventricular wedge preparations were made, transmembrane action potentials (TAP) from epicardium and endocardium were simultaneously recorded together with a transmural ECG. The incidence of EAD and Tdp with slow stimulation (2 000-4 000 ms) and hypokalemie (2 mmol/L), hypomagnesaemie (0. 25 mmol/L) Tyrode' s solution in left ventrieular wedge preparations was observed.② Myocytes were isolated by enzymatic method, and whole cell patch clamp technique was used to record the action potential. The incidence of EAD with slow stimulation (0.25-0.5 Hz) and hypokalemie (2.0 retool/L), hypomagnesaemie (0.25 retool/L) Tyrode's solution in single ventricular cells was observed. Results ①With slow stimulation and hypokalemic, hypomagnesaemic Tyrode's solution in left ventricular wedge preparations, the incidence of EAD in sham group, LVH group, KN-92 group (0.5 μmol/L) and KN-93 group (0.5 μmol/L) was 0/10, 10/10, 9/10 and 5/10 respeetively;The incidence of Tdp in sham group, LVH group, KN-92 group (0.5 μmol/L) and KN-93 group (0.5 μmol/L) was 0/10, 5/10, 4/10 and 1/10 respectively;②With slow stimulation and hypokalemic, hypomagnesaemic Tyrode's solution in single ventricular cells, the incidence of EAD in sham group, LVH group, KN-92 group (0, 5μmol/L) and KN-93 group (0, 5 μmol/L) was 0/12, 11/12, 10/12 and 5/12 respectively. Conclusion Calmodulin kinase Ⅱ mediates the occurrence of ventricular arrhythmias in rabbits with cardiac hypertrophy by increasing the incidence of EAD.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2007年第2期183-186,190,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30470714)
关键词 钙调蛋白激酶Ⅱ 心肌肥厚 室性心律失常 calmodulin kinase Ⅱ cardiac hypertrophy ventricular arrhythmias
  • 相关文献

参考文献13

  • 1ZHANG T, BROWN J H. Role of Ca^2+/calmodulin-dependent protein kinase Ⅱ in cardiac hypertrophy and heart failure[J]. Cardiovasc Res, 2004,63(3) : 476-486.
  • 2YAN G X, JOSHI A, GUO D, et al. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia [J]. Circulation, 2004, 110 (9) : 1036-1041.
  • 3YAN G X, RIALS S J, WU Y J,et al. Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization [J]. Am J Physiol Heart Circ Physiol,2001,281 (5) : H1968-H1973.
  • 4WU Y J,MACMILLAN L B, MCNEILL R B, et al. CaM kinase augments cardiac L-type Ca^2+ current:a cellular mechanism for long Q-T arrhythmias[J]. Am J Physiol Heart Circ Physiol,1999,276(6) : H2168-H2177.
  • 5ANDERSON M E. QT interval prolongation and arrhythmia:an unbreakable connection? [J]. 2006,259(1) :81-90.
  • 6COLOMER J M, MAO L, ROCKMAN H A,et al. Pressure overload selectively upregulates Ca^2+/calmodulin-dependent protein kinase Ⅱ in vivo [J]. Mol Endocrinol, 2003,17 (2):183-192.
  • 7卜军,张存泰,白融,刘念,李泱,王琳.钙调蛋白拮抗剂W-7抑制索他洛尔诱发离体兔心尖端扭转型室性心动过速[J].中华心血管病杂志,2005,33(4):364-368. 被引量:12
  • 8王文广,张存泰,吴杰,卜军,刘念,任勇,肖志超,王琳,陆再英.钙调蛋白抑制剂对陈旧性心肌梗死兔室性心律失常的影响[J].中国心脏起搏与心电生理杂志,2005,19(1):60-62. 被引量:7
  • 9DZHURA I,WU Y J,COLBRAN R J,et al. Calmodulin kinase determines calcium dependent facilitation of L-type calcium channels[J]. Nat Cell Biol,2000,2(3) :173-177.
  • 10AI X,CURRAN J W,SHANNON T R,et al. Ca^2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca^2+ leak in heart failure[J]. Circ Res, 2005, 97(12) : 1314-1322.

二级参考文献14

  • 1Mannhold R, Timmerman H. Putative therapeutic applic ations of calmodulin antagonists[J]. Pharm Weekbl Sci,1992,14(4):161.
  • 2Reek S, Bicknell JL, Walcott GP, et al. Inducibility of sustained ventricular tachycardia in a closed-chest ovine model of myocardial infarction[J]. PACE,1999,22:605.
  • 3Ruigrok TJC, Boink ABJ, Slade A, et al. The effect of verapamil on the calcium paradox [J]. Am J Pathol,1980,98:761.
  • 4Yang D, Song LS, Zhu WZ, et al. Calmodulin regulation of excitation-contraction coupling in cardiac myocytes[J]. Circ Res,2003,92(6):659.
  • 5Wu Y, MacMillan LB, McNeill RB, et al. CaM kinase augments cardiac L-type Ca2+ current: A cellular mechanism for long Q-T arrhythmias[J]. Am J Physiol,1999,276:H 2 168.
  • 6Anderson ME, Braun AP, Wu Y, et al. KN-93, an inhibitor of multifunctional Ca2+ /calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart[J]. J Pharmacol Exp Ther,1998,287:996.
  • 7Wu Y, Roden DM, Anderson ME. Calmodulin kinase inhibition prevents development of the arrhythmogenic transient inward current [J]. Circ Res,1999,84:906.
  • 8Meerson FZ, Malyshev IIu, Larionov NP, et al. Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine[J]. Kardiologiia, 1988,28(5):91.
  • 9Gbadebo TD, Trimble RW, Khoo MS, et al. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts inhibition of torsade de pointes[J]. Circulation, 2002,105:770.
  • 10Mazur A, Roden DM, Anderson ME. Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits[J]. Circulation,1999,100:2 437.

共引文献14

同被引文献73

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部